Skip to search.
 STI Down1.77%

GlaxoSmithKline plc (GSK)

-NYSE

52.97 Up 0.24(0.46%) 25 May 04:01 SGT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2011Dec 31, 2010Dec 31, 2009
Total Revenue 42,563,000   44,452,000   45,810,000  
Cost of Revenue11,395,000  11,886,000  11,918,000  
Gross Profit 31,168,000   32,566,000   33,893,000  
Operating Expenses
Research Development6,230,000  6,978,000  6,631,000  
Selling General and Administrative12,805,000  19,665,000  13,657,000  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 12,133,000   5,923,000   13,605,000  
Income from Continuing Operations
Total Other Income/Expenses Net1,049,000  195,000  (965,000)
Earnings Before Interest And Taxes13,206,000  6,244,000  12,743,000  
Interest Expense1,242,000  1,301,000   -  
Income Before Tax11,964,000  4,943,000  12,743,000  
Income Tax Expense3,481,000  2,042,000  3,588,000  
Minority Interest(306,000)(343,000)(223,000)
Net Income From Continuing Ops8,200,000  2,685,000  9,035,000  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 8,200,000   2,685,000   8,932,000  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 8,176,000   2,558,000   8,932,000  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.